Abbreviation
|
Definitions
|
CS |
cigarette smoke |
ROS |
reactive oxygen species |
COPD |
chronic obstructive pulmonary disease |
PF |
pulmonary fibrosis |
WHO |
World Health Organization |
FCTC |
Framework Convention on Tobacco Control |
NOX |
NADPH oxidase |
NETs |
neutrophil extracellular traps |
DAMP |
damage-associated molecular patterns |
RAGE |
receptor for advanced glycation end products |
HMGB1 |
high mobility group box 1 |
sRAGE |
soluble form RAGE |
mRAGE |
membrane-bound form RAGE |
TLRs |
toll-like receptors |
H1R |
histamine receptor-1 |
COX2 |
cyclooxygenase2 |
MAPK |
mitogen-activated protein kinase |
NF-κB |
nuclear factor kappa-light chain-enhancer of activated B cells |
IKK |
IκB kinase |
ERK1/2 |
extracellular signal-regulated kinases |
JNK1/2 |
c-Jun N-terminal Kinase |
STAT |
signal transducer and activator of transcription |
IRF9 |
interferon regulatory factor 9 |
CBP |
CREB-binding protein |
CSE |
cigarette smoke extract |
BAL |
bronchoalveolar lavage |
BCL-2 |
B-cell lymphoma 2 |
TP53 |
tumor protein p53 |
IAPs |
inhibitor of apoptosis proteins |
TSSK4 |
testis-specific serine/threonine kinase 4 |
NQO1 |
NAD(P)H dehydrogenase [quinone] 1 |
AKR1C3 |
aldo-keto reductase family 1 member C3 |
GPX2 |
glutathione peroxidase 2 |
ILD |
interstitial lung disease |
MMPs |
matrix metalloproteinases |
SIRT1 |
sirtuin-1 |
SASP |
senescence-associated secretory phenotype |
OSGIN |
oxidative stress-induced growth inhibitor |
Nrf2 |
nuclear factor erythroid 2-related factor |
Keap1 |
Kelch-like ECH-associated protein 1 |
ARE |
antioxidant response elements |
HO1 |
heme oxygenase 1 |
GST |
glutathione S-transferase |
FEV1 |
forced expiratory volume |
SOD1 |
superoxide dismutase type 1 |
TXNRD1 |
thioredoxin reductase 1 |
GOLD |
Global Initiative for Obstructive Lung Disease |
HUC-MSC |
Human umbilical cord mesenchymal system cell |
LPHNPs |
lipid-polymer hybrid nanoparticles |
EMT |
epithelial-mesenchymal transition |
SNPs |
single nucleotide polymorphisms |
CYP1A1 |
cytochrome P450 Family 1 Subfamily A Member 1 |
CYP1B1 |
cytochrome P450 Family 1 Subfamily B Member 1 |
CCL18 |
chemokine (C-C motif) ligand 18 |
CXCR3 |
chemokine (C-X-C motif) receptor 3 |
TIMPs |
tissue inhibitors of metalloproteinases |
miRNAs |
microRNAs |
PDE4B |
phosphodiesterase 4B |
iNOS |
inducible nitric oxide synthase |
HIF |
hypoxia-inducible factor |
NSCLC |
non-small-cell lung cancer |
mAbs |
monoclonal antibodies |
MSCs |
mesenchymal stem cells |
PAHs |
polycyclic aromatic hydrocarbons |
ARDS |
acute respiratory distress syndrome |
NE |
neutrophil elastase |
ACE2 |
angiotensin-converting enzyme 2 |
TMPRSS2/4 |
transmembrane protease, serine 2 and 4 |
ICAM-1 |
Intercellular adhesion molecule 1 |
AE-COPD |
acute exacerbations of chronic obstructive pulmonary disease |
FVC |
forced vital capacity |
CVD |
cardiovascular disease |
GMP |
guanosine monophosphate |
eNOS |
endothelial NOS |
NLR |
NOD-like receptor |
NLRP3 |
NLR family pyrin domain containing 3 |
sVCAM-1 |
soluble vascular cell adhesion molecule 1 |
LDL |
low-density lipoprotein |
oxLDL |
oxidized LDLs |
LOX-1 |
lectin-like oxidized LDL receptor-1 |